Headache: The Journal of Head and Face Pain

Is There a Preferred Triptan?
pp. 1-7(7)
Authors: Dodick, D.W.; Silberstein, S.; Dahlöf, C.G.H.

Evidence-Based Assessment of Pregnancy Outcome After Sumatriptan Exposure
pp. 8-15(8)
Authors: Fox, A.W.; Chambers, C.D.; Anderson, P.O.; Diamond, M.L.; Spierings, E.L.H.

Treatment of Migraine With Rizatriptan: When to Take the Medication
pp. 16-20(5)
Authors: Hu, X.H.; Raskin, N.H.; Cowan, R.; Markson, L.E.; Berger, M.L.; on

Almotriptan Increases Sustained Pain-Free Outcomes in Acute Migraine: Results From Three Controlled Clinical Trials
pp. 21-27(7)
Author: Dodick, D.W.

Within-Patient Early Versus Delayed Treatment of Migraine Attacks With Almotriptan: The Sooner the Better
pp. 28-31(4)
Authors: Pascual, J.; Cabarrocas, X.

A Long-term Open-Label Study of Oral Almotriptan 12.5 mg for the Treatment of Acute Migraine
pp. 32-40(9)
Authors: Mathew, N.T.; for

Frovatriptan for the Acute Treatment of Migraine: A Dose-Finding Study
pp. 41-48(8)
Authors: Goldstein, J.; Keywood, C.; on

Rizatriptan 5 mg for the Acute Treatment of Migraine in Adolescents: A Randomized, Double-Blind, Placebo-Controlled Study
pp. 49-55(7)
Authors: Winner, P.; Lewis, D.; Visser, W.H.; Jiang, K.; Ahrens, S.; Evans, J.K.; on

Naratriptan in the Prophylaxis of Cluster Headache
pp. 56-57(2)
Author: Loder, E.

New Paradigms in the Recognition and Acute Treatment of Migraine
pp. 58-69(12)
Authors: Sheftell, F.D.; Tepper, S.J.

Headache Recurrence as a Criterion for Assessing Efficacy of Triptans: A Perspective
pp. 70-79(10)
Author: Aurora, S.K.

The Patient's Perspective
pp. 80-81(2)
Author: Hannon, E.

Triptans for Migraine Prodrome
pp. 83-84(2)
Authors: Evans, R.W.; Mannix, L.K.

Control of Topiramate-Induced Paresthesias With Supplemental Potassium
pp. 85-85(1)
Author: Silberstein, S.D.

Topiramate-Induced Myopia
pp. 85-86(2)
Authors: Zweifler, R.M.; McKinley, B.; Duval, D.

Abstracts and Citations
pp. 87-90(4)